Nervus Intermedius Neuralgia
- PMID: 39847207
- DOI: 10.1007/s11916-024-01335-2
Nervus Intermedius Neuralgia
Abstract
Purpose of review: This review discusses the diagnosis and treatment of nervus intermedius neuralgia (NIN) and identifies gaps in the literature.
Recent findings: The nervus intermedius is a branch of the facial nerve. NIN presents as a rare neuralgia of this nerve, causing deep ear pain, which may radiate to the auditory canal, auricle, mastoid, soft palate, temple, and angle of the jaw. NIN most commonly presents in middle-aged women; neurovascular compression involving the anterior inferior cerebellar artery is the most common etiology described. Despite its diagnostic criteria in the International Classification of Headache Disorders, 3rd edition (ICHD-3), NIN may lack a trigger zone and may manifest as achy or neuralgiform pain instead of the typically described sharp or shooting pain. Like trigeminal neuralgia, NIN can be divided into classic, idiopathic, secondary, or painful neuropathy. Although there are no established guidelines for treating NIN, many possible treatments are used. Experience from treating trigeminal neuralgia suggests that carbamazepine or oxcarbazepine can be considered first-line. Patients with medically refractory NIN may benefit from neurosurgery referral for microvascular decompression or nerve sectioning. More research is needed to elucidate the range of clinical presentations in patients with NIN. Current data are limited and suggest that symptoms may diverge from the ICHD-3 diagnostic criteria. Although various treatments have been attempted, they often lack solid evidence and are typically derived from approaches used for other neuralgias. Proper diagnosis is crucial, particularly when considering surgical referral, due to the potential overlap of NIN with other neuralgias affecting the head and neck.
Keywords: Auditory canal; Ear; Facial nerve; Headache; Neurovascular compression; Pain.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval: N/A. Submission Category: Invited Review Financial Support: None provided for the development of this manuscript. Informed Consent: N/A. Competing Interests: Dr. Robblee discloses grant support from Barrow Neurological Foundation, investigator support from Eli Lilly and Abbvie, paid advisory board for Abbvie, advisory board for Tonix Pharmaceuticals, speaker for Impel, as well as paid editorial relationship with MedLink Neurology and Neurodiem. Dr. Robblee also discloses that a family member has partial ownership of Scottsdale Providence Recovery Center.
References
-
- Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalgia. 2018;38(1):1–211. https://doi.org/10.1177/0333102417738202 .
-
- Bruyn GW. Nervus intermedius neuralgia: (Hunt). Cephalalgia. 1984;4(1):71–8. https://doi.org/10.1046/j.1468-2982.1984.0401071.x .
-
- Robblee J. A pain in the ear: two case reports of nervus intermedius neuralgia and narrative review. Headache. 2021;61(3):414–21. https://doi.org/10.1111/head.14066 . - DOI - PubMed
-
- Chen Q, Yi DI, Perez JNJ, Liu M, Chang SD, Barad MJ, et al. The molecular basis and pathophysiology of trigeminal neuralgia. Int J Mol Sci. 2022;23(7). https://doi.org/10.3390/ijms23073604 .
-
- Coulter J, Kwon E, Otalgia. StatPearls. Treasure Island (FL): StatPearls Publishing; 2019.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
